Pinned
Recent advancements in one-shot AI protein / antibody development by Chai, Nabla, AI Proteins, Generate, and a few others are accelerating the *main* theme in biotech:
Value of building the molecule is going down. The value of novel targets, novel translational ideas, AND also
**A grand unified theory on what will happen in biotech in the next 10-20 years**
the two major forces reshaping industrial biotech in the next decade are:
1. China
2. AI
- and they're critically linked
how?
China's low R&D cost basis democratizes execution by providing
